← Open Payments lookup

MARYALICE CASE: Open Payments

NPI 1982310611 · CHICKASHA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,164 in 46 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,482 · 2025 $1,164

Food & beverage: $1,164
CompanyPaymentsAmount
ABBVIE INC.16$420
Alkermes, Inc.7$203
Otsuka America Pharmaceutical, Inc.11$196
Teva Pharmaceuticals USA, Inc.2$151
Novartis Pharmaceuticals Corporation2$40
Janssen Pharmaceuticals, Inc2$36
E.R. Squibb & Sons, L.L.C.2$35
Neurocrine BioSciences, Inc.1$27
Lundbeck LLC1$22
Abbott Laboratories1$18

Products named: VRAYLAR, UZEDY, LYBALVI, REXULTI, ARISTADA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, LEQVIO.

Industry payments across OK — which companies pay providers there.